Title

Secukinumab Treatment of Psoriatic Arthritis and Moderate to Severe Psoriasis Relieves Anxiety/Depression Up to 52 Weeks: An Overview From Secukinumab Phase 3 Clinical Trials

Document Type

Abstract

Publication Date

October 2017

Department

Dermatology

Share

COinS